Andrew Krahn < Andrew Lees (neurologue) < Andrew M. Gordon

Facettes :

List of bibliographic references indexed by Andrew Lees (neurologue)

Number of relevant bibliographic references: 62.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2013)	Renato Puppi Munhoz [Brésil] ; Hélio A. Teive [Brésil] ; Hariklia Eleftherohorinou [Royaume-Uni] ; Lachlan J. Coin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni, Brésil]	Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease
000197 (2011)	Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Pathological gambling in Parkinson's disease—a review of the literature
000253 (2011)	Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis]	Milestones in Parkinson's disease—Clinical and pathologic features
000274 (2011)	S. Sharma [Royaume-Uni] ; R. Bandopadhyay ; T. Lashley ; A. E. M. Renton [Royaume-Uni] ; A. E. Kingsbury ; R. Kumaran ; C. Kallis ; C. Vilari O-Güell ; S. S. O'Sullivan ; Andrew Lees (neurologue) [Royaume-Uni] ; T. Revesz ; N. W. Wood ; J. L. Holton	LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study
000345 (2011)	Helen Ling [Royaume-Uni] ; Mark Braschinsky [Estonie] ; Pille Taba [Estonie] ; Siiri-Merike Lüüs [Estonie] ; Karen Doherty [Royaume-Uni] ; Anna Hotter [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]	Decades of delayed diagnosis in 4 levodopa‐responsive young‐onset monogenetic parkinsonism patients
000483 (2010)	Nin P S. Bajaj [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; James Birchall [Royaume-Uni] ; James Patterson [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study
000490 (2010)	David A. Gallagher [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni]	What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
000549 (2010)	Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]	Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000553 (2010)	Atbin Djamshidian [Royaume-Uni, Autriche] ; Ashwani Jha [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Clare Jacobson [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Bruno B. Averbeck [Royaume-Uni]	Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease
000615 (2010)	Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni]	Olfactory heterogeneity in LRRK2 related Parkinsonism
000649 (2010)	Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède]	Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
000681 (2010)	Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy
000770 (2010)	Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]	Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
000844 (2010)	Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]	A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy
000883 (2009)	Juliane Neumann [Royaume-Uni, Allemagne] ; Jose Bras [États-Unis, Portugal, Royaume-Uni] ; Emma Deas [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Laura Parkkinen [Royaume-Uni] ; Robin H. Lachmann [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Rita Guerreiro [États-Unis, Portugal, Royaume-Uni] ; Reema Paudel [Royaume-Uni] ; Badmavady Segarane [Royaume-Uni] ; Andrew Singleton [États-Unis, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni]	Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
000906 (2009)	M. Selikhova [Royaume-Uni, Russie] ; D. R. Williams [Royaume-Uni, Australie] ; P. A. Kempster [Royaume-Uni, Australie] ; J. L. Holton [Royaume-Uni] ; T. Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	A clinico-pathological study of subtypes in Parkinson's disease
000920 (2009)	Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni]	Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study
000930 (2009)	Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni]	The use of a color coded probability scale to interpret smell tests in suspected parkinsonism
000A86 (2009)	Sarah Teixeira Camargos [Brésil] ; Leonardo Oliveira Dornas [Brésil] ; Parastoo Momeni [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Francisco Cardoso [Brésil]	Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations
000B43 (2009)	A H Evans [Australie, Royaume-Uni] ; A D Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson’s disease
000B72 (2009)	Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]	Adherence to antiparkinson medication in a multicenter European study

---

List of associated KwdEn.i

Nombre de documents	Descripteur
22	Parkinson's disease
4	LRRK2
4	apomorphine
4	depression
4	olfaction
3	Lewy bodies
3	parkin
3	parkinsonism
3	smell
2	MSA
2	PSP
2	UPSIT
2	autonomic
2	diagnosis
2	diagnostic criteria
2	dopamine agonists
2	impulse control disorder
2	neuropathology
2	progressive supranuclear palsy
2	substantia nigra
1	ADD = additional integrated image
1	AMPA receptor antagonist
1	ARSAC = Administration of Radioactive Substances Advisory Committee
1	BDI = Beck Depression Inventory
1	BP = binding potential
1	Brazil
1	CingA = anterior cingulate cortex
1	DA = dopaminergic; 2DGE = two‐dimensional gel electrophoresis; GFAP = glial fibrillary acidic protein; IR = immunoreactivity, immunoreactive; LB = Lewy body; LN =Lewy neurite; PSP = progressive supranuclear palsy; SN = substantia nigra
1	DAT = dopamine transporter
1	DJ‐1; Parkinson’s disease; immunohistochemistry; 2D gel electrophoresis; paraquat
1	DaTSCAN
1	F-dopa PET = 18F-dopa positron emission tomography
1	FP‐CIT SPECT
1	G2019S mutation
1	James Parkinson
1	LOD = logarithm of the odds
1	LRRK2 = leucine-rich, repeat kinase 2
1	LRRK2 mRNA
1	LRRK2 protein
1	L‐dopa
1	L‐dopa challenge
1	NAT = noradrenaline transporter
1	NFTs = neurofibrillary tangles
1	NHNN = National Hospital for Neurology and Neurosurgery
1	PARK2
1	PARK8
1	PD dementia
1	PET imaging
1	PINK1
1	PRKN
1	Parkinson
1	Parkinson disease
1	Parkinson's
1	Parkinson's disease dementia
1	Parkinson's disease.
1	ROI = region of interest
1	SNCA
1	SPECT
1	SPM = statistical parametric mapping
1	Sniffin sticks
1	Sniffin' Sticks
1	Sri Lanka
1	Tretiakoff
1	UPDRS = Unified Parkinson's Disease Rating Scale
1	UPSIT = University of Pennsylvania Smell Identification Test
1	adverse effects
1	anxiety
1	atypical parkinsonism
1	cM = centimorgan
1	catecholamines
1	chronic fatigue syndrome
1	clinical diagnostic criteria
1	clinical features
1	clinical trial
1	clinico‐radiological correlations
1	compulsions
1	conversion disorder
1	criteria
1	dardarin
1	delaying levodopa
1	dementia
1	differential diagnosis
1	diffusion‐weighted MRI
1	dopamine disregulation
1	dopamine transporter
1	dyskinesia
1	dyskinesias
1	entacapone
1	executive functions
1	founder effect
1	gambling
1	genetics
1	health status
1	impulse control
1	impulse control disorders
1	juvenile parkinsonism
1	levodopa
1	levodopa‐induced dyskinesias
1	limbic system
1	memory

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Andrew Lees (neurologue)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Andrew Lees (neurologue)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Andrew Lees (neurologue)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024